BSPED Banner
  • About
    About the BSPED History Aims and Governing documents Benefactors Committees Activities
  • Training
    SpR Training Trainees Forum Postgraduate Training Day
  • Clinical
    Standards Documents Endorsed Guidelines Supported Guidelines Expert Opinions Position Statements Audit Special Interest Groups
  • Nurses
    Endocrine Nurses Diabetes Nurses Endocrine Nurse Training Nurse Forum Diabetes Nurse Training
  • Meetings
    Forthcoming BSPED Meetings Previous BSPED Meetings Other Meetings
  • Research
    MCRN BSPED Clinical Studies Group BSPED Clinical Trials Unit BSPED Supported Research BSPED Supported Research Publications
  • Awards
    Research Awards Nurse Awards Travel Grants Award Winners
  • Resources
    Professional Resources Diabetes information Endocrinology information Evidence Based Medicine Genetics Medical Books Medical Journals Medical Resources Paediatrics Research Grants
  • Patients
    Patients Information Patients Resources
You are here:  Home > Clinical
Clinical
Expert Opinions
The expert opinions included on this page have been approved by the BSPED and reflect the Society's views on best practice for the average patient. Each patient must be considered as an individual in the context of their condition and other medication, and whilst every effort has been made to ensure the factual accuracy of the contents no liability can be accepted for any litigation, claims or complaints arising from the use of the expert opinion, which is solely at the discretion of the reader.
The views and exact treatment regimens are those of the author and are provided as a service by the BSPED website with this proviso.
The Hypothalamopituitary Axis Tumour (HPAT) virtual MDT
Anyone wishing to share a case discussion on patients with a difficult craniopharyngioma or other midline hypothalamopituitary axis tumour (HPAT) are welcome to join the virtual MDT interest group chaired every 3rd Tuesday 12.00-13.00h from GOSH with endocrine, neuro-oncology, neurosurgical and neuroradiological colleagues.
To join you will need:
  • a nominated endocrine/neuro-oncology and neurosurgical lead for your centre.
  • to inform stephanie.ingram@gosh.nhs.uk of the case one week in advance if possible (phone 0207-405-9200 Xt 0403) and with a copy to our manager sarah.maloney@gosh.nhs.uk.
  • to arrange for a neuroradiologist to present your scans at your end or IEP your scans across the Monday before to adreano.greco@gosh.nhs.uk.
  • a pre-arranged and tested IT link arranged with dan.brecht@gosh.nhs.uk and a prior connection check at 11.45h before each MDT.
Connection details required to dial to connect to the next & any future meetings for this MDT:
Room Name: Midline Tumour MDT, Room PIN Number: 2039, N3 Address: 2039@10.101.63.197 or 10.101.63.197 and choose Midline Tumour MDT from the Auto Attendant Menu. Internet IP Address: 2039@195.194.165.254 or 195.194.165.254 and choose Midline Tumour MDT from the Auto Attendant Menu ISDN Number: 0207 320 2039.
BSPED Endorsed Expert Opinions
Creation Date Revision Date
Vitamin D Expert Opinion (50kb) Dec 2009 Nov 2012


 

© 2011  Disclaimer Privacy Policy Accessibility Contact Terms and Conditions Designed, hosted and maintained by BioScientifica
bsped logo